$BRZE Cashflow Statement | Understand Stock

$BRZE

$45.78 -$0.06 (0.13%) Close

$BRZE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jan 31, 2026	FY2025 12 months to Jan 31, 2025	FY2024 12 months to Jan 31, 2024	FY2023 12 months to Jan 31, 2023	FY2022 12 months to Jan 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss (including amounts attributable to redeemable non-controlling interests)
Adjustments to reconcile net loss to net cash provided by operating activities:
Stock-based compensation
Amortization of deferred contract costs
Depreciation and amortization
Provision for credit losses
Amortization of discount/premium on marketable securities
Value of common stock donated to charity
Accretion of discount on marketable securities
Non-cash foreign exchange (gain) loss
Deferred income taxes
Fair value adjustments to contingent consideration
Fixed asset write offs
Other
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Deferred contract costs
ROU assets and liabilities
Other assets
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue
Other long-term liabilities
Net cash provided by operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for acquisition, net of cash acquired
Purchases of property and equipment
Capitalized internal-use software costs
Purchases of marketable securities
Maturities of marketable securities
Return of principal on marketable securities
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock upon initial public offering, net of offering costs
Investment from redeemable non-controlling interest
Proceeds from exercise of common stock options
Proceeds from stock associated with employee stock purchase plan
Repurchase of shares related to early exercised options
Payments of deferred purchase consideration
Net cash provided by financing activities
Effect of foreign currency exchange rate changes on cash, cash equivalents, and restricted cash
Net change in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash, beginning of period
Cash, cash equivalents, and restricted cash, end of period
SUPPLEMENTAL CASH FLOW DISCLOSURE:
Cash paid for income taxes, net of refunds
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock-based compensation capitalized to internal-use software
Net change in capitalized internal-use software development costs in accrued expenses
Unrealized net gain on marketable investment securities
Net change to property and equipment (included in accounts payable)
Net change to property and equipment (included in accounts payable / accrued liabilities)
Vesting of early exercised options
Common stock option receivables
Conversion of convertible preferred stock to common stock
Deferred offering costs reclassed to Stockholders’ Equity (Deficit)
Asset retirement obligation
Common stock issuance, acquisition
Contingent consideration, acquisition
Indemnity escrows, acquisition

Comments